These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18379458)

  • 21. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
    Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
    Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of actovegin in the treatment of elderly patients with vascular mild cognitive impairment].
    Mikhaĭlova NM; Selezneva ND; Kalyn IaB; Roshchina IF; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):69-76. PubMed ID: 23994934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological syndromes associated with Alzheimer's/vascular dementia: a latent class analysis.
    Libon DJ; Drabick DA; Giovannetti T; Price CC; Bondi MW; Eppig J; Devlin K; Nieves C; Lamar M; Delano-Wood L; Nation DA; Brennan L; Au R; Swenson R
    J Alzheimers Dis; 2014; 42(3):999-1014. PubMed ID: 25024329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the ten-point clock test to compare executive functioning across 24 months in patients with subcortical vascular dementia.
    Moretti R; Torre P; Antonello RM; Cazzato G; Bava A; Manos PJ
    Percept Mot Skills; 2005 Feb; 100(1):207-16. PubMed ID: 15773712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trajectories of cognitive decline in different types of dementia.
    Smits LL; van Harten AC; Pijnenburg YA; Koedam EL; Bouwman FH; Sistermans N; Reuling IE; Prins ND; Lemstra AW; Scheltens P; van der Flier WM
    Psychol Med; 2015 Apr; 45(5):1051-9. PubMed ID: 25229325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between orthostatic hypotension and cognitive impairment in the elderly.
    Mehrabian S; Duron E; Labouree F; Rollot F; Bune A; Traykov L; Hanon O
    J Neurol Sci; 2010 Dec; 299(1-2):45-8. PubMed ID: 20855089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of amantadine sulfate on cognitive disorders in patients with Parkinson's disease].
    Iablonskaia AIu; Fedorova NV; Bel'gusheva ME
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):24-30. PubMed ID: 20639853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)].
    Bugrova SG; Novikov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders].
    Levin OS; Batukaeva LA; Anikina MA; Iunishchenko NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):42-6. PubMed ID: 20032953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation.
    Wolters M; Hickstein M; Flintermann A; Tewes U; Hahn A
    Prev Med; 2005 Jul; 41(1):253-9. PubMed ID: 15917019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of memantine for elderly patients in the mild stage of Alzheimer's and vascular dementia].
    Bachyns'ka NIu; Rozheliuk IF; Polietaieva KM; Kholin VO
    Lik Sprava; 2013; (7):80-96. PubMed ID: 25509921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia.
    Rainer M; Kraxberger E; Haushofer M; Mucke HA; Jellinger KA
    J Neural Transm (Vienna); 2000; 107(12):1475-81. PubMed ID: 11459000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of patients with movement and cognitive disorders in the residual period of stroke].
    Agafonov BV; Podrezova LA; Karavashkina EA; Vishniakova TI; Smirnova LA; Dadasheva MN; Shevtsova NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):55-8. PubMed ID: 21626819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combination of green tea extract and l-theanine improves memory and attention in subjects with mild cognitive impairment: a double-blind placebo-controlled study.
    Park SK; Jung IC; Lee WK; Lee YS; Park HK; Go HJ; Kim K; Lim NK; Hong JT; Ly SY; Rho SS
    J Med Food; 2011 Apr; 14(4):334-43. PubMed ID: 21303262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
    Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
    Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pattern of neuropsychological deficits in Vascular Cognitive Impairment-No Dementia (Vascular CIND).
    Nyenhuis DL; Gorelick PB; Geenen EJ; Smith CA; Gencheva E; Freels S; deToledo-Morrell L
    Clin Neuropsychol; 2004 Feb; 18(1):41-9. PubMed ID: 15595357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric manifestations in vascular cognitive impairment patients with and without dementia.
    Chiu PY; Liu CH; Tsai CH
    Acta Neurol Taiwan; 2007 Jun; 16(2):86-91. PubMed ID: 17685132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of neuropsychological impairment in Alzheimer's disease and mixed dementia.
    Dong Y; Gan DZ; Tay SZ; Koay WI; Collinson SL; Hilal S; Venketasubramanian N; Chen C
    J Neurol Sci; 2013 Oct; 333(1-2):5-8. PubMed ID: 23978422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.